Protalix is a publicly traded biotechnology company
(NYSE Amex: PLX),
that is producing recombinant therapeutic proteins through the ProCellEx™ plant cell system.
HOME PAGE
ABOUT US
Corporate Profile
Market Needs
Protalix Advantage
Management Team
Scientific Advisory Board
Press Room
Careers
TECHNOLOGY
ProCellEx Overview
Platform Technology
Protein Production
PRODUCT DEVELOPMENT
taliglucerase alfa (UPLYSO)
Pipeline Products
PARTNERSHIPS
INVESTORS
Corporate Strategy
Board of Directors
Management Team
Stock Information
Corporate Governance
Filings
Press Releases
FAQs
EVENT CALENDER
CONTACT US
Patients
Investor Relations
Corporate Strategy
Board of Directors
Management Team
Stock Information
Corporate Governance
Filings
Analyst Coverage
Press Releases
FAQs
STOCK INFORMATION
© 2007 Protalix Biotherapeutics. All Rights Reserved.
